The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
Jia‐Wei Lv(Zhejiang Chinese Medical University), Jun Ma(Shanghai Jiao Tong University), Wei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Jia-Li Guan(Sun Yat-sen University), Dong‐Ming Kuang(Sun Yat-sen University), Yu‐Pei Chen(Sun Yat-sen University), Jianhua Yin(BGI Group (China)), Guan‐Qun Zhou(Sun Yat-sen University), Jiayi Shen(Sun Yat-sen University), Zhuoli Huang(BGI Group (China)), Yuan Zhang(Sun Yat-sen University), Qing‐Mei He(Sun Yat-sen University), Xiaoyu Liang(Sun Yat-sen University), Ying Sun(Qilu Hospital of Shandong University), Xin Jin(BGI Group (China)), Ling‐Long Tang(Sun Yat-sen University), Yan‐Ping Mao(Sun Yat-sen University), Wei Chen(University of Pittsburgh), Na Liu(Sun Yat-sen University), Siqi Wang(Peking University), Xiaomin Li(Committee on Publication Ethics), Wenwen Zhou(BGI Group (China)), Rui Guo(Sun Yat-sen University), Rui Sun(Qilu Hospital of Shandong University), Cuijuan Zhang(BGI Group (China)), Shiwei He(Sun Yat-sen University), Wen‐Fei Li(Sun Yat-sen University), Yuhui Zheng(BGI Group (China)), Guibo Li(BGI Group (China)), Ke-Xu Xiong(BGI Group (China)), Junyan Li(Sun Yat-sen University)
Cited by 104
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|643
Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing
|The American Journal of Human Genetics|2013|496